Geldanamycin Production Cost Reports

The report provides a detailed analysis essential for establishing a Geldanamycin production plant. It encompasses all critical aspects necessary for Geldanamycin production, including the cost of Geldanamycin production, Geldanamycin plant cost, Geldanamycin production costs, and the overall Geldanamycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a Geldanamycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Geldanamycin, a benzoquinone ansamycin antibiotic isolated from Streptomyces species, is mainly utilised in pharmaceutical research and drug development as an Hsp90 inhibitor. It functions as an important lead compound for the synthesis of semisynthetic derivatives like 17-AAG (tanespimycin) and pimitespib. These derivatives target cancer cells by disrupting Hsp90 chaperone activity, leading to degradation of oncoproteins such as kinases, steroid receptors, and p53.

Additionally, these derivatives have advanced to clinical trials for oncology, including gastrointestinal stromal tumours, and show promise in HIV/AIDS, malaria, and neurodegenerative diseases through modulation of multiple signalling pathways.

The market demand for Geldanamycin is driven by its foundational role as an Hsp90 inhibitor in oncology research and biopharmaceutical development. The rising demand for derivatives like tanespimycin (17-AAG) and pimitespib in targeted cancer therapies for gastrointestinal stromal tumours and solid cancers also boosts the market growth. Additionally, advancements in fermentation-based synthesis, PROTAC degrader platforms, and biotech investments in precision medicine propel the market growth.

Industrial geldanamycin procurement is influenced by its niche role as a research-grade Hsp90 inhibitor, with key factors including raw material sourcing from Streptomyces fermentation processes, which affects scalability and cost stability.

Raw Material for Geldanamycin Production

According to the Geldanamycin production plant project report, the raw material for Geldanamycin production includes protected macrolactam precursor and trichloroacetylisocyanate.

Production Process of Geldanamycin

The extensive Geldanamycin production cost report consists of the following major industrial production process:

1. Production via chemical synthesis: The production process of Geldanamycin from lactam (protected macrolactam precursor) involves a concise three-step sequence. In the first step, trichloroacetylisocyanate is added to lactam in dichloromethane (DCM), stirred for 20 min, concentrated, then treated with K2CO3 in MeOH for 2 h to form the carbamate. In the next step, this carbamate undergoes AlCl3-mediated deprotection in DCM/anisole at -78 degree Celsius to rt for 3 h, quenched with MeOH/NaHCO3, yielding crude yellow dihydroquinone after extraction and drying. Finally, air oxidation with 10% Pd/C in EtOAc at rt for 20 min, followed by filtration through Celite and purification (PE/EtOAc, 2:1), produces Geldanamycin.

Properties of Geldanamycin

Geldanamycin (C29H40N2O9, molecular weight 560.65 g/mol) is a yellow powder solid with a melting point near 255 degree Celsius, boiling point of 628 degree Celsius, density ~1.24 g/cm³, and refractive index ~1.58. It has low solubility in ethanol but up to 10 mg/mL in DMSO, and requires -20 degree Celsius storage due to the reactive benzoquinone moiety prone to nucleophilic additions at C17 and C19. This 19-membered macrocyclic lactam features a benzoquinone ring, three methoxy groups, C9-carbamate, and defined stereochemistry (4E,6Z,8S,9S,10E,12S,13R,14S,16R), enabling a compressed C-shaped conformation for Hsp90 ATPase inhibition where the ansa-chain (C1-12) binds deeply into the protein pocket while the aromatic core acts as a lid. Its stability involves trans-to-cis amide shift upon Hsp90 binding, with flash point 87 degree Celsius and no auto-ignition noted, though quinone-driven hepatotoxicity underscores reactivity limits.